Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.
Sachpekidis C, Eder M, Kopka K, Mier W, Hadaschik BA, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Among authors: hadaschik ba. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1288-99. doi: 10.1007/s00259-015-3302-4. Epub 2016 Jan 12. Eur J Nucl Med Mol Imaging. 2016. PMID: 26753602
68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer.
Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Sachpekidis C, et al. Clin Nucl Med. 2016 Nov;41(11):e473-e479. doi: 10.1097/RLU.0000000000001349. Clin Nucl Med. 2016. PMID: 27607173 Free article.
[Significance of PSMA imaging in prostate cancer].
Gasch C, Düwel C, Kopka K, Kratochwil C, Vinsensia M, Eiber M, Maurer T, Haberkorn U, Hadaschik B, Giesel FL. Gasch C, et al. Among authors: hadaschik b. Urologe A. 2017 Jan;56(1):3-12. doi: 10.1007/s00120-016-0293-0. Urologe A. 2017. PMID: 28005153 Clinical Trial. German.
Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study.
Kesch C, Vinsensia M, Radtke JP, Schlemmer HP, Heller M, Ellert E, Holland-Letz T, Duensing S, Grabe N, Afshar-Oromieh A, Wieczorek K, Schäfer M, Neels OC, Cardinale J, Kratochwil C, Hohenfellner M, Kopka K, Haberkorn U, Hadaschik BA, Giesel FL. Kesch C, et al. J Nucl Med. 2017 Nov;58(11):1805-1810. doi: 10.2967/jnumed.116.189233. Epub 2017 May 4. J Nucl Med. 2017. PMID: 28473595 Free article.
[Significance and Value of PSMA Ligands in Prostate Cancer].
Gasch C, Körber S, Kremer C, Eiber M, Kratochwil C, Haberkorn U, Hohenfellner M, Hadaschik B, Giesel FL. Gasch C, et al. Among authors: hadaschik b. Aktuelle Urol. 2017 Apr;48(2):140-147. doi: 10.1055/s-0043-100269. Epub 2017 May 16. Aktuelle Urol. 2017. PMID: 28511220 Review. German.
Therapy assessment in prostate cancer using choline and PSMA PET/CT.
Ceci F, Herrmann K, Hadaschik B, Castellucci P, Fanti S. Ceci F, et al. Among authors: hadaschik b. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):78-83. doi: 10.1007/s00259-017-3723-3. Epub 2017 May 25. Eur J Nucl Med Mol Imaging. 2017. PMID: 28540419 Review.
426 results